Searched for
WOCKHARDT RESULTS
Ahead of Market: 10 things that will decide D-Street action on MondayIndian benchmark indices ended marginally lower on Friday as investors assessed the RBI’s decision to keep rates unchanged while raising in...- F&O Talk: Nifty may consolidate further; Sudeep Shah's strategy on TCS, HDFC Bank, InfosysIndian stock markets, Sensex and Nifty, closed lower following the RBI's hawkish stance, despite falling oil prices. Analyst Sudeep Shah an...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
- Turnaround Story: 10 stocks shift from loss to profit in March '26 quarterTen Nifty500 companies successfully moved from net losses in the March '25 quarter to significant net profits in March '26. Noteworthy turn...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Ahead of Market: 10 things that will decide stock market action on ThursdayDomestic equities surged as crude oil slipped below $100 and US-India trade optimism boosted sentiment. Nifty and Sensex gained over 1%, le...
- Gainers & Losers: Vodafone Idea, ONGC among 7 big stock movers on WednesdayDomestic markets surged Wednesday as oil fell below $100. Nifty and Sensex rose over 1%, with notable stock-specific movements across secto...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weaknessSmallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 ear...
- Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growthWockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performanc...
- Wockhardt Q2 Results: Co swings to profit at Rs 82 croreDrug firm Wockhardt on Monday reported a consolidated profit after tax of Rs 82 crore for the second quarter ended September 30, 2025.
- Wockhardt Q3 Results: Firm reports cons loss at Rs 102 croreConsolidated revenue from operations stood at Rs 699 crore in the quarter under review as compared to Rs 854 crore in the year-ago period, ...
- Wockhardt Q3 Results: Firm posts consolidated profit of Rs 1.77 crIncome from continuing operations rose to Rs 853.89 crore in the third quarter as against Rs 764.02 crore in the October-December period of...
- Wockhardt Q4 results: Net loss at Rs 106.84 croreThe consolidated total income of the company for the quarter under consideration stood at Rs 639.50 crore. It was Rs 700.66 crore for the s...
- Wockhardt slips over 2% ahead of earningsWockhardt slips over 2% ahead of earningsWockhardt Ltd slipped over 2 percent on Tuesday to touch its day’s low of Rs 680 ahead of its quar...
Load More
